Apyx Medical
APYX
51 hedge funds and large institutions have $18.1M invested in Apyx Medical in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 14 closing their positions.
47,800% more call options, than puts
Call options by funds: $479K | Put options by funds: $1K
11.89% less ownership
Funds ownership: 50.38% → 38.5% (-12%)
18% less funds holding
Funds holding: 62 → 51 (-11)
52% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 21
60% less capital invested
Capital invested by funds: $45.7M → $18.1M (-$27.6M)
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.06M |
| 2 |
RA
Royce & Associates
New York
|
+$591K |
| 3 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$180K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$57.6K |
| 5 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$40.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.35M |
| 2 |
RI
RTW Investments
New York
|
-$2.69M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$1.36M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.11M |
| 5 |
Millennium Management
New York
|
-$404K |
APYX Hedge Fund Activity: Q1 2024 in Review
51 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2024, worth a combined $18.1M — down 60% from $45.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of APYX and 3 opened new positions — a net loss of 11 holders — while 21 trimmed existing stakes and 10 added.
The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $1.06M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $5.35M sold.
- 51 institutional investors held Apyx Medical (APYX) as of Q1 2024, down from 62 in Q4 2023.
- Funds reported $18.1M of Apyx Medical stock for Q1 2024, down 60% quarter-over-quarter.
- 3 funds opened new Apyx Medical positions in Q1 2024 and 14 closed out, a net change of -11 holders.
- The largest Apyx Medical buyer in Q1 2024 was Commonwealth Equity Services, an estimated $1.06M added.
- The largest Apyx Medical seller in Q1 2024 was AIGH Capital Management, an estimated $5.35M sold.
Based on aggregated 13F filings for Q1 2024.